Tertiary Educational Trust Fund under her National Research Fund (NRF) awarded research grant worth N37,436,737.00(Thirty seven million, four hundred and thirty sixty thousand, seven hundred and thirty seven naira) to Kogi State University,Anyigba on the 18th April,2019. The research is titled “Development of New Generation Blood-stage malaria Vaccine” by Professor James Omale, the Principl Researcher.
Dr. Emmanuel Amlabu is the active Researcher on the research team.
Dr. Amlabu was awarded both B.Sc. and M.Sc. degrees in Biochemistry at the Amadu Bello University, Zaria, Nigeria in 2004 and 2008 respectively under the supervision of late Professor A.J. Nok.
In 2015, he was awarded the Auturo Falaschi ICGEB Fellowship during which he obtained a PhD degree in life Sciences at Jawaharlal Nehru University in New Delhi, India. He is a growing academic staff at the department of Biochemistry, kogi State University, and Anyigba, Nigeria. His major research output during his PhD studies was published in the 2015 edition of the proceedings of the national Academy of Science (PNAS), https://www.pnas.org/content/112/4/1179 was highlighted in Nature Reviews Microbiology, https://www.nature.com/article/nrmicro.3436. His research exhibition on New generation blood-stage malaria vaccine development emerged 1st position in the category Individual Research in Life Sciences and Medicine at the 6th Nigeria Universities Research and Development Fair organized by the National Universities Commission (NUC) held at Akwa, Nigeria, http://nuc .edu.ng/wp-content/uploads/2015/01/MB 21st march final pdf. In 2016, the Committee of Vice Chancellors (CVC) of Nigerian Federal Universities presented the award for Research Excellence to him for his work in the area of malaria vaccine development in 2018. He was awarded the WACCBIP- Welcome Trust DELTAS postdoctoral Fellowship at the University of Ghana where he published another important finding from the research in the Journal of Infectious Diseases (JID), https://academic.oup.com/jid/article/218/5/778/4975396. It is foreseen that the wealth of research training he is acquiring will impact positively in the global fight against malaria.